The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy
Abstract Background Hepatitis C affects over 185 million people around the world. This silent disease is responsible for up to 700,000 deaths per year. Despite the scientific revolution in diagnosis and treatment, hepatitis C control remains a huge challenge due to the cost of effective medications....
Main Authors: | Fabio Mesquita, Melina Erica Santos, Adele Benzaken, Renato Girade Corrêa, Elisa Cattapan, Leandro Soares Sereno, Marcelo Contardo Moscoso Naveira |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-11-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12889-016-3784-4 |
Similar Items
-
Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
by: Megen C. Wittling, et al.
Published: (2021-01-01) -
Editorial: Structures, Signaling Mechanisms, and Functions of Types I and III Interferons
by: Ronald L. Rabin, et al.
Published: (2021-02-01) -
Insights Into Type I and III Interferons in Asthma and Exacerbations
by: Helen E. Rich, et al.
Published: (2020-09-01) -
Regulation of the human interferon-b promoter
by: Xanthoudakis, Steven
Published: (1990) -
The expression of interferon-stimulated genes (interferon “signature”) in patients with rheumatoid arthritis (Preliminary results)
by: A. S. Avdeeva, et al.
Published: (2021-01-01)